Home/Filings/4/0001209191-05-033317
4//SEC Filing

Waddington Simon 4

Accession 0001209191-05-033317

CIK 0001028318other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 9:22 PM ET

Size

81.8 KB

Accession

0001209191-05-033317

Insider Transaction Report

Form 4
Period: 2005-06-21
Transactions
  • Conversion

    Common Stock Warrant

    2005-06-21+71,46371,463 total(indirect: Polytechnos Medical Devices Ltd.)
    Exercise: $7.52Common Stock (71,463 underlying)
  • Conversion

    Common Stock

    2005-06-21+2,3292,329 total(indirect: Polytechnos Partners & Team GMBH)
  • Exercise of In-Money

    Common Stock Warrant

    2005-06-2171,4630 total(indirect: Polytechnos Medical Devices Ltd.)
    Exercise: $7.52Common Stock (71,463 underlying)
  • Conversion

    Common Stock Warrant

    2005-06-21+20,66020,660 total(indirect: Polytechnos Venture Fund II LP)
    Exercise: $7.52Common Stock (20,660 underlying)
  • Exercise of In-Money

    Common Stock

    2005-06-21+1432,472 total(indirect: Polytechnos Partners & Team GMBH)
  • Conversion

    Series D-3 Preferred Stock

    2005-06-2130,7760 total(indirect: Polytechnos Venture Fund II LP)
    Common Stock (30,776 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2005-06-213330 total(indirect: Global Venture Advisors GMBH)
    Exercise: $7.52Common Stock (333 underlying)
  • Conversion

    Serries D Preferred Warrant

    2005-06-2120,6600 total(indirect: Polytechnos Venture Fund II LP)
    Exercise: $7.52Series D Preferred Stock (20,660 underlying)
  • Conversion

    Common Stock

    2005-06-21+291,404291,404 total(indirect: Polytechnos Venture Fund II LP)
  • Conversion

    Series D Preferred Stock

    2005-06-21153,8850 total(indirect: Polytechnos Venture Fund II LP)
    Common Stock (153,885 underlying)
  • Conversion

    Series D Preferred Stock

    2005-06-2138,3320 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)
    Common Stock (38,332 underlying)
  • Conversion

    Series D-3 Preferred Stock

    2005-06-217,6660 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)
    Common Stock (7,666 underlying)
  • Conversion

    Series D Preferred Warrant

    2005-06-2171,4630 total(indirect: Polytechnos Medical Devices Ltd.)
    Exercise: $7.52Series D Preferred Stock (71,463 underlying)
  • Conversion

    Series D Preferred Warrant

    2005-06-212600 total(indirect: Polytechnos Partners & Team GMBH)
    Exercise: $7.52Series D Preferred Stock (260 underlying)
  • Conversion

    Common Stock Warrant

    2005-06-21+260260 total(indirect: Polytechnos Partners & Team GMBH)
    Exercise: $7.52Common Stock (260 underlying)
  • Conversion

    Series D-3 Preferred Stock

    2005-06-216660 total(indirect: Global Venture Advisors GMBH)
    Common Stock (666 underlying)
  • Conversion

    Series E Preferred Stock

    2005-06-2126,5880 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)
    Common Stock (26,588 underlying)
  • Conversion

    Common Stock

    2005-06-21+532,268532,268 total(indirect: Polytechnos Medical Devices Ltd.)
  • Exercise of In-Money

    Common Stock

    2005-06-21+2,84475,430 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)
  • Conversion

    Common Stock

    2005-06-21+72,58672,586 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)
  • Conversion

    Common Stock

    2005-06-21+666666 total(indirect: Global Venture Advisors GMBH)
  • Exercise of In-Money

    Common Stock

    2005-06-21+106772 total(indirect: Global Venture Advisors GMBH)
  • Exercise of In-Money

    Common Stock

    2005-06-21+11,420302,824 total(indirect: Polytechnos Venture Fund II LP)
  • Exercise of In-Money

    Common Stock Warrant

    2005-06-2120,6600 total(indirect: Polytechnos Venture Fund II LP)
    Exercise: $7.52Common Stock (20,660 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2005-06-211940 total(indirect: Polytechnos Partners & Team GMBH)
    Exercise: $7.52Common Stock (194 underlying)
  • Exercise of In-Money

    Common Stock

    2005-06-21+22,641554,909 total(indirect: Polytechnos Medical Devices Ltd.)
  • Conversion

    Series D Preferred Stock

    2005-06-21532,2680 total(indirect: Polytechnos Medical Devices Ltd.)
    Common Stock (532,268 underlying)
  • Conversion

    Series D-3 Preferred Stock

    2005-06-213880 total(indirect: Polytechnos Partners & Team GMBH)
    Common Stock (388 underlying)
  • Conversion

    Series D Preferred Warrant

    2005-06-215,1460 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)
    Exercise: $7.52Series D Preferred Stock (5,146 underlying)
  • Conversion

    Series D Preferred Stock

    2005-06-211,9410 total(indirect: Polytechnos Partners & Team GMBH)
    Common Stock (1,941 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2005-06-215,1460 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)
    Exercise: $7.52Common Stock (5,146 underlying)
  • Conversion

    Series E Preferred Stock

    2005-06-21106,7430 total(indirect: Polytechnos Venture Fund II LP)
    Common Stock (106,743 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2005-06-212600 total(indirect: Polytechnos Partners & Team GMBH)
    Exercise: $7.52Common Stock (260 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2005-06-2115,3880 total(indirect: Polytechnos Venture Fund II LP)
    Exercise: $7.52Common Stock (15,388 underlying)
  • Conversion

    Common Stock Warrant

    2005-06-21+5,1465,146 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)
    Exercise: $7.52Common Stock (5,146 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2005-06-213,8330 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)
    Exercise: $7.52Common Stock (3,833 underlying)
Footnotes (8)
  • [F1]Converts on a 1 to 1 basis.
  • [F2]The shares were acquired by the net exercise of warrants.
  • [F3]N/A
  • [F4]The Common Warrants were converted and exercised for Common Stock at the closing of the initial public offering.
  • [F5]The warrants were net exercised.
  • [F6]Immediately Exerciseable
  • [F7]Five years from the date of issuance or at the close of initial public offering.
  • [F8]The Series D Preferred Warrants were converted and exercised for Common Stock at the closing of the initial public offering.

Issuer

MICRUS ENDOVASCULAR CORP

CIK 0001028318

Entity typeother

Related Parties

1
  • filerCIK 0001325627

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:22 PM ET
Size
81.8 KB